Related Experiment Videos
[Hereditary ovarian cancer].
M Zikán1, L Foretová, D Cibula
1Gynekologicko-porodnická klinika 1 LF UK a VFN, Praha. michal.zikan@lf1.cuni.cz
Ceska Gynekologie
|June 14, 2006
Summary
Identifying hereditary ovarian cancer risk is crucial for early detection and prevention. Genetic counseling and molecular analysis, focusing on BRCA1/BRCA2 genes, aid in managing hereditary cancer syndromes.
Area of Science:
- Oncology
- Genetics
- Hereditary Cancer Syndromes
Context:
- Hereditary ovarian cancer presents in three autosomal dominant syndromes: hereditary ovarian cancer (HOC), hereditary breast and ovarian cancer (HBOC), and hereditary non-polyposis colorectal cancer (HNPCC).
- Identifying at-risk individuals involves family history assessment for early-onset or multiple occurrences of breast and/or ovarian cancers.
Purpose:
- To review hereditary ovarian cancer, identify at-risk populations, and outline genetic counseling and molecular analysis protocols.
- To provide guidance on genetic testing for hereditary cancer predisposition, including BRCA1 and BRCA2 gene analysis.
Summary:
- Molecular genetic analysis of key susceptibility genes like BRCA1 and BRCA2 is recommended for assessing hereditary predisposition to ovarian and breast cancer.
- Genetic analysis should be guided by experienced clinical geneticists, with specialized centers available in the Czech Republic (Prague and Brno).
Impact:
- Proactive management of individuals with hereditary cancer susceptibility can significantly prevent malignancies or enable early-stage detection.
- Establishes a framework for genetic and clinical care of at-risk patients, improving outcomes for hereditary cancer syndromes.